Jamieson, D, Griffin, M, Sludden, J, Drew, Y, Cresti, N, Swales, K, Merriman, M, Allen, R, Bevan, P, Buerkle, M, Mala, C, Coyle, V, Rodgers, L, Dean, E, Greystoke, A, Banerji, U, Wilson, R, Evans, J, Anthoney, A, Ranson, M, Boddy, A & Plummer, R 2016, ' A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours ', European Journal of Cancer, vol. 68 . https://doi.org/10.1016/j.ejca.2016.08.026 Jamieson, D, Griffin, M J, Sludden, J, Drew, Y, Cresti, N, Swales, K, Merriman, M, Allen, R, Bevan, P, Buerkle, M, Mala, C, Coyle, V, Rodgers, L, Dean, E, Greystoke, A, Banerji, U, Wilson, R H, Evans, T R J, Anthoney, A, Ranson, M, Boddy, A V & Plummer, R 2016, ' A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours ', European Journal of Cancer, vol. 68, pp. 1-10 . https://doi.org/10.1016/j.ejca.2016.08.026
British Journal of Cancer Evans, T R J, Dean, E, Molife, L R, Lopez, J, Ranson, M, El-Khouly, F, Zubairi, I, Savulsky, C, Reyderman, L, Jia, Y, Sweeting, L, Greystoke, A, Barriuso, J & Kristeleit, R 2019, ' Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours ', British Journal of Cancer . https://doi.org/10.1038/s41416-019-0377-x
Soria, J C, Gan, H K, Blagden, S P, Plummer, R, Arkenau, H T, Ranson, M, Evans, T R J, Zalcman, G, Bahleda, R, Hollebecque, A, Lemech, C, Dean, E, Brown, J, Gibson, D, Peddareddigari, V, Murray, S, Nebot, N, Mazumdar, J, Swartz, L, Auger, K R, Fleming, R A, Singh, R & Millward, M 2017, ' A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors ', Annals of Oncology . https://doi.org/10.1093/annonc/mdw427
British Journal of Cancer Gibb, A, Greystoke, A, Ranson, M, Linton, K, Neeson, S, Hampson, G, Illidge, T, Smith, E, Dive, C, Pettitt, A, Lister, A, Johnson, P & Radford, J 2013, ' A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity ', BJC, vol. 109, no. 10, pp. 2560-2565 . https://doi.org/10.1038/bjc.2013.605